(Washington, D.C.) —  The Pharmaceutical Care Management Association (PCMA) issued the following statement on the Trump Administration’s actions today to outline the steps that drug companies must take to lower the prices of prescription drugs for Americans:

“PCMA commends the president for his continued commitment to lowering prescription drug prices. Americans are paying the highest prices in the world when it comes to prescriptions – and that’s not right.

“America’s pharmacy benefit managers (PBMs) support lower prices for every prescription drug for every patient and have called on drug companies to lower list prices to make medicines more affordable. PBMs stand ready to pull through lower drug prices to health plans and patients as well as continue to administer pharmacy benefits and clinical programs that help patients safely access lower cost medications.

“Drug companies alone set and raise drug prices and can lower the list prices at any time. In addition, some drug companies block lower cost generics and biosimilars from entering the market, leading to Americans paying the highest prescription drug prices in the world.

“We look forward to continuing to support the Administration’s goal of making prescription drugs more accessible and affordable for Americans.

###

PCMA is the national association representing America’s pharmacy benefit companies. Pharmacy benefit companies are working every day to secure savings, enable better health outcomes, and support access to quality prescription drug coverage for more than 289 million patients.